We are live on ! Find out more
GC

Globeflex Capital Portfolio holdings

AUM $661M
1-Year Est. Return 50.59%
This Fund
S&P 500
This Quarter Est. Return
+7.9%
1 Year Est. Return
+50.59%
3 Year Est. Return
+135.47%
5 Year Est. Return
+202.82%
10 Year Est. Return
+1,069.65%
AUM
$490M
AUM Growth
+$17.5M
Cap. Flow
-$3.43M
Cap. Flow %
-0.7%
Top 10 Hldgs %
16.21%
Holding
469
New
39
Increased
155
Reduced
195
Closed
44

Top Buys

Rank Stock Value
1
EWY icon
iShares MSCI South Korea ETF
EWY
+$1.96M
2
USFD icon
US Foods
USFD
+$1.45M
3
CPA icon
Copa Holdings
CPA
+$1.41M
4
ICUI icon
ICU Medical
ICUI
+$1.29M
5
WHD icon
Cactus
WHD
+$1.27M

Sector Composition

Rank Sector Weight
1 Healthcare 18.16%
2 Industrials 15.87%
3 Consumer Discretionary 15.01%
4 Financials 14.72%
5 Technology 12.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
G icon
201
Genpact
G
$5.87B
$848K 0.17%
29,310
-484
-2% -$15K
QVCGA
202
DELISTED
QVC Group Inc Series A
QVCGA
$847K 0.17%
822
-12
-1% -$13.3K
EGRX
203
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$847K 0.17%
11,200
-19,700
-64% -$1.24M
COR icon
204
Cencora
COR
$62.2B
$843K 0.17%
9,883
-157
-2% -$13.8K
WSBF icon
205
Waterstone Financial
WSBF
$372M
$839K 0.17%
49,200
AMKR icon
206
Amkor Technology
AMKR
$11.3B
$832K 0.17%
96,800
-200
-0.2% -$1.82K
OC icon
207
Owens Corning
OC
$11.5B
$830K 0.17%
13,092
-16,397
-56% -$1.13M
SAH icon
208
Sonic Automotive
SAH
$3.31B
$827K 0.17%
40,146
+5,103
+15% +$106K
ANIP icon
209
ANI Pharmaceuticals
ANIP
$1.84B
$822K 0.17%
12,300
+1,200
+11% +$74.9K
TPB icon
210
Turning Point Brands
TPB
$1.56B
$821K 0.17%
+25,734
New +$642K
MAS icon
211
Masco
MAS
$16.5B
$818K 0.17%
21,849
-361
-2% -$13.9K
RBCAA icon
212
Republic Bancorp
RBCAA
$1.97B
$815K 0.17%
18,000
+2,200
+14% +$94.9K
WOR icon
213
Worthington Enterprises
WOR
$2.82B
$804K 0.16%
31,074
-72
-0.2% -$2.04K
MTG icon
214
MGIC Investment
MTG
$6.47B
$803K 0.16%
74,945
-9,863
-12% -$107K
AXE
215
DELISTED
Anixter International Inc
AXE
$802K 0.16%
12,674
-1,573
-11% -$105K
PRSU
216
Pursuit Attractions and Hospitality Inc
PRSU
$1.48B
$801K 0.16%
14,765
-30,687
-68% -$1.63M
BGC icon
217
BGC Group
BGC
$5.73B
$799K 0.16%
109,732
-51
-0% -$408
MYGN icon
218
Myriad Genetics
MYGN
$502M
$793K 0.16%
21,230
+5,600
+36% +$189K
CIEN icon
219
Ciena
CIEN
$49.6B
$788K 0.16%
29,742
-4,607
-13% -$117K
SHOE
220
Shoe Station Group
SHOE
$431M
$787K 0.16%
48,514
-2,400
-5% -$33.5K
EDN
221
Edenor
EDN
$1.11B
$781K 0.16%
24,049
+12,017
+100% +$582K
CNP icon
222
CenterPoint Energy
CNP
$29B
$778K 0.16%
28,076
-451
-2% -$11.8K
MERC icon
223
Mercer International
MERC
$45.6M
$777K 0.16%
44,400
+18,800
+73% +$283K
PRFT
224
DELISTED
Perficient Inc
PRFT
$775K 0.16%
29,400
-9,200
-24% -$231K
KINS icon
225
Kingstone Companies
KINS
$292M
$772K 0.16%
45,700
+5,900
+15% +$102K

Similar funds

Globeflex Capital's Q2 2018 Portfolio in Review

As of Q2 2018, Globeflex Capital held 469 positions worth $490M, up 3.7% from $473M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Globeflex Capital's Q2 2018 filing shows 39 new, 155 increased, 195 reduced and 44 closed positions. Its largest new stake was US Foods: 41,029 shares worth $1.55M. The largest sale was Apollo Global Management, an estimated $2.14M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Globeflex Capital's largest Q2 2018 buy was US Foods: 41,029 shares worth $1.55M.
  • Globeflex Capital added most to iShares MSCI South Korea ETF in Q2 2018, an estimated $1.96M increase.
  • Globeflex Capital's biggest Q2 2018 reduction was Pursuit Attractions and Hospitality Inc, cutting an estimated $1.63M.
  • Globeflex Capital fully exited Apollo Global Management in Q2 2018, selling an estimated $2.14M.
  • Globeflex Capital's ten largest holdings make up 16% of its $490M portfolio in Q2 2018.
  • Globeflex Capital opened 39 new positions and closed 44 in Q2 2018.
  • Globeflex Capital's portfolio value rose 3.7% quarter-over-quarter to $490M.

Based on Globeflex Capital's 13F filing for Q2 2018, filed 10 Aug 2018.